Sio Gene Therapies Inc.
SIOXDelisted Apr 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001636050
Sio Gene Therapies Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Feb 10, 2022; 37 institutions reported holding it in 13F filings for Q4 2022, worth $8.09M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Sio Gene Therapies Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
SIOX is no longer listed, so this page shows Q4 2022. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 37
- 0 vs. Q3 2022
- Shares held
- 18.6M
- −2.37M (−11.3%) vs. Q3 2022
- Total value
- $8.09M
- +$2.22M (+37.8%) vs. Q3 2022
- New holders
- 6
- 6 more added
- Sold out
- 6
- 13 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SIOX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 1 | $26.0K |
| Q1 2023 | 4 | $1.13M |
| Q4 2022 | 37 | $8.09M |
| Q3 2022 | 38 | $5.91M |
| Q2 2022 | 41 | $7.44M |
| Q1 2022 | 40 | $12.1M |
| Q4 2021 | 48 | $27.6M |
| Q3 2021 | 55 | $39.9M |
| Q2 2021 | 53 | $56.1M |
| Q1 2021 | 55 | $53.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Sio Gene Therapies Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 132 | $0 | 0.00% | −184−58.2% | Reduced |
| Advisor Group Holdings, Inc. | 86 | $0 | 0.00% | 00.0% | Unchanged |
| Fifth Third Bancorp | 125 | $54 | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 125 | $54 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 244 | $106 | 0.00% | +130+114.0% | Added |
| Group One Trading, L.P. | 902 | $392 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 1,305 | $1.00K | 0.00% | −687−34.5% | Reduced |
| Wells Fargo & Company | 2,373 | $1.03K | 0.00% | +2,011+555.5% | Added |
| Wolff Wiese Magana LLC | 2,400 | $1.04K | 0.00% | 00.0% | Unchanged |
| Primecap Management Co | 12,000 | $5.22K | 0.00% | −3,600−23.1% | Reduced |
| StoneX Group Inc. | 13,913 | $6.05K | 0.00% | +13,913 | New |
| Citadel Advisors LLC | 15,202 | $6.61K | 0.00% | +15,202 | New |
| Bridgeway Capital Management, LLC | 15,600 | $6.79K | 0.00% | −89,800−85.2% | Reduced |
| Merit Financial Group, LLC | 15,750 | $6.85K | 0.00% | −2,000−11.3% | Reduced |
| Tower Research Capital LLC (TRC) | 15,453 | $7.00K | 0.00% | −22,853−59.7% | Reduced |
| Boothbay Fund Management, LLC | 30,000 | $13.1K | 0.00% | 00.0% | Unchanged |
| Franklin Resources Inc | 55,570 | $24.2K | 0.00% | 00.0% | Unchanged |
| Macquarie Group Ltd | 64,170 | $28.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 70,925 | $30.9K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 80,100 | $35.2K | 0.00% | +75,573+1,669.4% | Added |
| Northern Trust Corp | 87,153 | $37.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 95,387 | $41.5K | 0.00% | +95,387 | New |
| Cladis Investment Advisory, LLC | 150,000 | $65.3K | 0.06% | −402,000−72.8% | Reduced |
| State Street Corp | 173,621 | $75.5K | 0.00% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 235,000 | $102.2K | 0.00% | −1,445,536−86.0% | Reduced |
| Clearline Capital LP | 250,024 | $108.8K | 0.02% | −142,667−36.3% | Reduced |
| Western Standard LLC | 294,397 | $128.1K | 0.11% | +294,397 | New |
| BlackRock Inc. | 390,386 | $169.8K | 0.00% | −70.0% | Reduced |
| Renaissance Technologies LLC | 409,284 | $178.0K | 0.00% | +47,284+13.1% | Added |
| JBF Capital, Inc. | 429,600 | $186.9K | 0.05% | +429,600 | New |
| Geode Capital Management, LLC | 432,270 | $188.0K | 0.00% | −1,116−0.3% | Reduced |
| Morgan Stanley | 1,512,380 | $657.9K | 0.00% | +1,500,000+12,116.3% | Added |
| Vanguard Group Inc | 1,739,923 | $756.9K | 0.00% | −100,784−5.5% | Reduced |
| Tang Capital Management LLC | 2,000,000 | $870.0K | 0.13% | +2,000,000 | New |
| Newtyn Management, LLC | 3,000,000 | $1.30M | 0.27% | +1,500,000+100.0% | Added |
| Rubric Capital Management LP | 7,000,000 | $3.04M | 0.13% | 00.0% | Unchanged |
| Tower View Investment Management & Research LLC | 5,239 | – | – | −6,406−55.0% | Reduced |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −5,914,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −99,324−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −94,150−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Hudock, Inc. | 0 | $0 | 0.00% | −179−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |